TAT Technologies Ltd. Q2 2026 Earnings Call Summary

TAT Technologies Ltd. reported Q2 2026 revenue up 23% and a record $650 million backlog, citing improved supply conditions. The company expanded its Honeywell Aerospace spare-parts distribution deal for the 331-200/250 APU through 2036. Management said profitability was temporarily pressured by inventory investment and higher procurement costs, while working capital stays elevated. Nonrecurring items included a $4.3M gross gain and a $900k tax charge.

Original reporting
Published Aug 7, 2026, 8:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 8:58 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
TAT Technologies Ltd. Q2 2026 Earnings Call Summary — source image
Decision brief

The 30-second read

Med
01

Why it matters

Traders may re-rate TAT’s aftermarket revenue durability due to the extended Honeywell agreement through 2036, while also reassessing near-term profitability and cash conversion given inventory build, procurement cost pressure, and elevated working capital.

02

Market read

The combination of a $650M record backlog and a Honeywell deal extension through 2036 is likely the core bull catalyst, tempered by inventory and working-capital drag and ongoing supply-chain lead times.

03

What to watch

FX losses (shekel strength) and the timing of cash conversion for revenue recognized but not yet collected could dominate the next quarter’s earnings quality.

Relevance 7/10Novelty 6/10Timing: pre-market today, Q2 2026 earnings call summary

Background

TAT’s Q2 2026 earnings call emphasizes record revenue growth and backlog, alongside a strategic expansion of its Honeywell Aerospace spare-parts distribution relationship for APU platforms.

Market effects

Supports the view that commercial aviation aftermarket MRO demand remains resilient, while supply-chain normalization is uneven (lead times still beyond 12 months).

No clear regional market transmission beyond FX sensitivity (shekel vs USD) noted in results.

Honeywell distribution extension through 2036 reinforces long-cycle global aftermarket parts demand and may affect competitive dynamics in APU spare parts.

Counterpoint

The long-term Honeywell visibility may be offset by persistent landing-gear supply constraints and elevated working capital, limiting near-term free cash flow despite revenue growth.

Key entities

  • TAT Technologies Ltd.

    Subject of the earnings call summary, reporting record quarter performance and expanded Honeywell distribution rights.

  • Honeywell Aerospace

    Expanded strategic relationship with TAT, extending APU spare parts distribution license to 2036 and granting sole global authorized distributor status for specified APU platform parts.

  • Israeli shekel (ILS)

    FX headwind cited in Q2 results, with losses over $600,000 due to shekel strength versus USD.

Related articles

$TATTMedAI 8/10

TAT Technologies Stock Jumps 18% On Q2 Earnings And Revenue Growth

TAT Technologies Ltd. (TATT) shares rose about 18% to $49.08 on Wednesday after the company reported Q2 results. Net earnings increased to $8.07 million, or $0.61 per share, from $3.44 million, or $0.30 per share, a year earlier. Revenue grew 22.8% to $52.94 million. The stock traded on Nasdaq between $48.90 and $52.99.

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.